Literature DB >> 15870706

Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice.

Frauke Krepulat1, Jürgen Löhler, Christina Heinlein, Andrea Hermannstädter, Genrich V Tolstonog, Wolfgang Deppert.   

Abstract

We describe the construction and phenotypic characterization of 23 whey acidic protein (WAP)-mutp53 transgenic mouse lines. The mutp53-expressing lines showed a mosaic expression pattern for the transgenes, leading to a heterogeneous yet mouse line-specific expression pattern for mutp53 upon induction. Only few lines were obtained, in which the majority of the induced mammary epithelial cells expressed the mutp53 transgene, most of the transgenic lines did not express mutp53, or expressed the transgene in less than 2% of the induced mammary epithelial cells. Hormone requirements for mutp53 transgene expression from the WAP-promoter differed in high and low expressing lines, being low in high expressing lines, and even lower in multiparous mutp53 mice, where persistent expression of the transgene occurred. Repeated induction of mutp53 expression through repeated parturition resulted in the formation of expanding mutp53-expressing foci within the mammary alveolar epithelium. The data suggest that epigenetic mechanisms play a role in modulating the expression of the mutp53 transgene. To support this idea, we crossed a nonexpressing WAP-mutp53 line with a strongly SV40 T-antigen-expressing WAP-T mouse line. In the bitransgenic mice, T-antigen-induced chromatin remodeling led to re-expression of epigenetically silenced mutp53 transgene(s). In these mice, mutp53 expression was much more variable compared to SV40 T-antigen expression, and seemed to depend on the coexpression of SV40 T-antigen. Mutp53 expression in this system thus resembles the situation in many human tumors, where one can observe a heterogeneous expression of mutp53, despite a homogeneous distribution of the p53 mutation in the tumor cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870706     DOI: 10.1038/sj.onc.1208557

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Modeling human protein aggregation cardiomyopathy using murine induced pluripotent stem cells.

Authors:  Pattraranee Limphong; Huali Zhang; Elisabeth Christians; Qiang Liu; Michael Riedel; Kathryn Ivey; Paul Cheng; Katie Mitzelfelt; Graydon Taylor; Dennis Winge; Deepak Srivastava; Ivor Benjamin
Journal:  Stem Cells Transl Med       Date:  2013-02-19       Impact factor: 6.940

2.  eIF4E threshold levels differ in governing normal and neoplastic expansion of mammary stem and luminal progenitor cells.

Authors:  Svetlana Avdulov; Jeremy Herrera; Karen Smith; Mark Peterson; Jose R Gomez-Garcia; Thomas C Beadnell; Kathryn L Schwertfeger; Alexey O Benyumov; J Carlos Manivel; Shunan Li; Anja-Katrin Bielinsky; Douglas Yee; Peter B Bitterman; Vitaly A Polunovsky
Journal:  Cancer Res       Date:  2014-12-18       Impact factor: 12.701

3.  Mutant p53 establishes targetable tumor dependency by promoting unscheduled replication.

Authors:  Shilpa Singh; Catherine A Vaughan; Rebecca A Frum; Steven R Grossman; Sumitra Deb; Swati Palit Deb
Journal:  J Clin Invest       Date:  2017-04-10       Impact factor: 14.808

4.  Elastic transformation of histological slices allows precise co-registration with microCT data sets for a refined virtual histology approach.

Authors:  Jonas Albers; Angelika Svetlove; Justus Alves; Alexander Kraupner; Francesca di Lillo; M Andrea Markus; Giuliana Tromba; Frauke Alves; Christian Dullin
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

5.  A site-specific recombinase-based method to produce antibiotic selectable marker free transgenic cattle.

Authors:  Yuan Yu; Yongsheng Wang; Qi Tong; Xu Liu; Feng Su; Fusheng Quan; Zekun Guo; Yong Zhang
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

Review 6.  The rebel angel: mutant p53 as the driving oncogene in breast cancer.

Authors:  Dawid Walerych; Marco Napoli; Licio Collavin; Giannino Del Sal
Journal:  Carcinogenesis       Date:  2012-07-20       Impact factor: 4.944

7.  Tumorigenic WAP-T mouse mammary carcinoma cells: a model for a self-reproducing homeostatic cancer cell system.

Authors:  Florian Wegwitz; Mark-Andreas Kluth; Claudia Mänz; Benjamin Otto; Katharina Gruner; Christina Heinlein; Marion Kühl; Gabriele Warnecke; Udo Schumacher; Wolfgang Deppert; Genrich V Tolstonog
Journal:  PLoS One       Date:  2010-08-11       Impact factor: 3.240

8.  Characterization of bioactive recombinant human lysozyme expressed in milk of cloned transgenic cattle.

Authors:  Bin Yang; Jianwu Wang; Bo Tang; Yufang Liu; Chengdong Guo; Penghua Yang; Tian Yu; Rong Li; Jianmin Zhao; Lei Zhang; Yunping Dai; Ning Li
Journal:  PLoS One       Date:  2011-03-16       Impact factor: 3.240

9.  TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.

Authors:  Pavla Brachova; Samuel R Mueting; Matthew J Carlson; Michael J Goodheart; Anna M Button; Sarah L Mott; Donghai Dai; Kristina W Thiel; Eric J Devor; Kimberly K Leslie
Journal:  Int J Oncol       Date:  2014-11-11       Impact factor: 5.650

Review 10.  Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development.

Authors:  Mayur V Jain; Anna M Paczulla; Thomas Klonisch; Florence N Dimgba; Sahana B Rao; Karin Roberg; Frank Schweizer; Claudia Lengerke; Padideh Davoodpour; Vivek R Palicharla; Subbareddy Maddika; Marek Łos
Journal:  J Cell Mol Med       Date:  2013-01-10       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.